Inactive Instrument
Quotes GENFIT Euronext Paris
Stocks
FR0004163111
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 03/07 | Genfit soars on news of U.S. reimbursement for a product | |
| 03/07 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Stock exchange
Euronext Paris- €
-
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GNFT | 13.78EUR | -0.58% | 17.5L € | ||
CBOE
| GNFTp | 13.70EUR | -1.30% | 4L € | |
Börse Stuttgart
| XUP | 13.70EUR | -0.58% | 1L € | |
Tradegate
| XUP | 13.80EUR | -0.58% | 10T € | |
Boerse Muenchen
| XUP | 13.76EUR | -0.72% | 6.88T € | |
OTC Markets
| GNFT.F | 15.75USD | -3.26% | 6.14T $ | |
CBOE
| 0QT6 | 13.95EUR | -2.38% | 4.84T € | |
Xetra
| XUP | 14.08EUR | -1.81% | 2.77T € | |
Deutsche Boerse AG
| XUP | 13.78EUR | -3.50% | 0 € | |
London S.E.
| 0QT6 | 13.74EUR | -0.72% | 0 € |
Basic data
Market Cap (EUR)
68,93,33,792
Market Cap (USD)
80,10,85,174
Net sales (EUR)
7,11,15,000
Net sales (USD)
8,26,43,812
Free-Float
86.89 %
Free-Float capitalization (EUR)
59,91,22,292
Free-Float capitalization (USD)
69,62,49,032
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 80Cr | ||
| -2.54% | -2.84% | -1.77% | +14.72% | 4.89TCr | ||
| -0.40% | +1.03% | +418.57% | +523.39% | 4.5TCr | ||
| -1.42% | +2.30% | +42.67% | +21.22% | 4.41TCr | ||
| -1.22% | -2.31% | +4.82% | +74.90% | 4.07TCr | ||
| +0.53% | -1.36% | +16.87% | +47.12% | 3.35TCr | ||
| -0.21% | +9.14% | - | - | 1.78TCr | ||
| -0.35% | -1.56% | +21.42% | +123.04% | 1.65TCr | ||
| -1.01% | +0.50% | +13.91% | +31.45% | 1.47TCr | ||
| -1.65% | -1.03% | +75.93% | +41.22% | 1.38TCr | ||
| Average | -0.92% | +0.53% | +74.05% | +109.63% | 2.76TCr | |
| Weighted average by Cap. | -1.03% | +0.11% | +89.42% | +127.93% |
Historical Quotes: GENFIT
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- GNFT Stock
- Stock
- Quotes GENFIT
Select your edition
All financial news and data tailored to specific country editions

















